Gyre Therapeutics, Inc. announced on June 28, 2024, Nassim Usman, Ph.D. informed the Company that he intended to resign from the Board, effective as of June 30, 2024. In addition, on June 28, 2024, Dr. Usman stepped down as a member of the Audit Committee, effective June 30, 2024. Dr. Usman?s resignation was not due to any disagreements with the Company relating to the Company?s operations, policies or practices.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.42 USD | +6.42% |
|
+10.36% | -47.76% |
07-05 | Gyre Therapeutics, Inc. Announces Resignation of Nassim Usman to Its Board, Effective June 30, 2024 | CI |
07-02 | Gyre Wins China Approval for Tablet to Treat Thrombocytopenia | DJ |
1st Jan change | Capi. | |
---|---|---|
-47.76% | 1.19B | |
+22.15% | 46.56B | |
+45.94% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- GYRE Stock
- News Gyre Therapeutics, Inc.
- Gyre Therapeutics, Inc. Announces Resignation of Nassim Usman to Its Board, Effective June 30, 2024